New Jersey’s overdose crisis is easing. Overdose deaths among state residents fell from 2,985 in 2022 to 1,992 in 2024, according to federal mortality data I analyzed. That is welcome news. It also makes this a good moment to ask a harder question: Is New Jersey’s share of the national opioid settlements going where people are still dying?
For the half of the money that goes directly to local governments, Essex County suggests the answer is no.
From 2022 through 2024, Essex County recorded 1,087 overdose deaths, more than any other county in the state and about 14% of the statewide total. Deaths there fell in 2024, to 268, but Essex still had more than any other county that year, as it did in 2022 and 2023. It was one of only two counties, along with Atlantic, where the overdose death rate in those years was higher than it had been from 2018 through 2021.
Yet local governments in Essex received about $10.6 million in national opioid settlement payments from 2022 through 2024, according to KFF Health News’s payout tracker. That is about 7% of what New Jersey’s counties and towns received in the tracker, or roughly $9,800 for every overdose death. In Bergen County, local governments received about $29,000 per death. In Morris, Somerset and Hunterdon, it was more than $28,000. Cumberland, Mercer, Atlantic and Hudson counties also fell below the statewide figure of about $18,900 per death. Atlantic County, which had the state’s highest overdose death rate, about 61 per 100,000 residents a year, received about $13,700 per death.
Payments per death are not a perfect yardstick. Counties differ in treatment capacity, population and other needs. But a threefold gap between Essex and Bergen is hard to explain by need alone.
The money that does arrive is not moving quickly. Essex County’s government has received about $3.2 million since 2022. In its report for the fiscal year ended June 30, 2026, it reported no expenditures of settlement funds. The county said it had developed a framework and recommendations but “has not actually finalized specific spending allocations by year.” In a December 2025 review of county reports, the National Center for Advocacy and Recovery reported that counties across the state still held roughly $70 million in unspent funds.
Part of the problem is structural. Half of New Jersey’s settlement money, which will total at least $1 billion through 2038, goes directly to 262 counties and municipalities. Their shares follow percentages set by a national formula that weighed opioid shipments, overdose deaths and opioid use disorder. They are not recalculated each year as deaths shift.
The state controls the other half, and it has more room to adjust. As of June 30, 2026, the state government had received about $246 million in settlement funds, and it has committed much of it to worthwhile programs, from harm reduction centers to housing for people in recovery. But when the state’s latest settlement report asked whether it had completed a risk assessment for demographic or geographic impact, the answer was: “No, but we plan to in the future.”
That assessment matters more than it might seem. In my own research, I analyzed 546 counties in 38 states, including New Jersey’s. Counties that were allocated more settlement money per resident did not see faster declines in overdose deaths through 2024. That pattern is not proof that the money failed: allocations, payments and actual spending are different things, and programs take time to work. It does suggest that dollars alone will not close the gap. Where the money lands, and how quickly it is put to work, will matter.
New Jersey can take three steps.
First, the Department of Human Services should complete its geographic assessment before the next round of state grants, comparing each county’s overdose deaths with the settlement money flowing to it. Counties where local payments per death fall furthest below the state average, led by Essex, should be first in line for state-funded programs.
Second, the state should help idle money move. Counties that have spent little of their funds should publish a spending timeline, and the state should offer them ready-made options, such as joining state-funded programs or partnering with neighboring counties, so that the money does not sit idle.
Third, the state should publish one simple table each year: overdose deaths, treatment admissions, settlement dollars received and settlement dollars spent, county by county. Residents should not need a research project to learn whether the money is reaching the places that need it most.
The settlements will keep paying New Jersey for more than a decade. The decline in deaths gives the state time to get the targeting right. It should not waste that time.

